Public limited company · Ath · incorporated on 12/12/1991 · 5,8 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 645,5 k € | -40.5% | 1,1 M € | +30.3% | 832,2 k € | +63.6% | 508,6 k € | +36.9% | 371,5 k € | +28.1% | 290,1 k € | +43.7% | 201,8 k € | -3.9% | 210,1 k € | -22.4% | 270,7 k € | +23.0% | 220,1 k € | -13.5% | 254,6 k € | +16.5% | 218,5 k € | +0.1% | 218,4 k € | -8.4% | 238,5 k € | -1.6% | 242,3 k € | +126.3% | 107,1 k € | +47.0% | 72,8 k € | +0.6% | 72,4 k € | +55.1% | 46,6 k € | |
| EBITDA | 235,6 k € | -68.3% | 742,2 k € | +108.3% | 356,4 k € | +25.0% | 285,0 k € | +24.8% | 228,3 k € | +57.0% | 145,4 k € | +35.1% | 107,6 k € | -7.8% | 116,7 k € | +56.3% | 74,7 k € | -8.9% | 82,0 k € | -32.0% | 120,6 k € | +15.9% | 104,1 k € | -6.7% | 111,6 k € | +20.4% | 92,7 k € | +3.2% | 89,8 k € | +57.5% | 57,0 k € | +134.7% | 24,3 k € | -31.3% | 35,3 k € | +40.3% | 25,2 k € | |
| Operating profit | 253,5 k € | -64.0% | 705,1 k € | +112.8% | 331,4 k € | +82.4% | 181,7 k € | -3.9% | 189,0 k € | +81.5% | 104,1 k € | +71.9% | 60,5 k € | +4.6% | 57,9 k € | +153.5% | 22,8 k € | -6.6% | 24,5 k € | -45.1% | 44,5 k € | +0.5% | 44,3 k € | +24.2% | 35,7 k € | +28.8% | 27,7 k € | +85.8% | 14,9 k € | +6.7% | 14,0 k € | +75.1% | 8,0 k € | -18.6% | 9,8 k € | +32.2% | 7,4 k € | |
| Profit/loss | 171,2 k € | -66.9% | 517,2 k € | +125.5% | 229,3 k € | +71.2% | 134,0 k € | -5.5% | 141,9 k € | +75.7% | 80,7 k € | +299.9% | 20,2 k € | +37.6% | 14,7 k € | +527.9% | -3,4 k € | -138.3% | 8,9 k € | -72.6% | 32,7 k € | +49.9% | 21,8 k € | +43.5% | 15,2 k € | +110.4% | 7,2 k € | +253.9% | -4,7 k € | -1426.3% | 354,0 € | +405.7% | 70,0 € | -97.8% | 3,2 k € | +171.5% | 1,2 k € | |
| Equity | 896,3 k € | +19.3% | 751,6 k € | +85.8% | 404,4 k € | +55.5% | 260,1 k € | +21.8% | 213,5 k € | +27.5% | 167,5 k € | +77.3% | 94,4 k € | +0.4% | 94,1 k € | +3.2% | 91,2 k € | -9.2% | 100,4 k € | -6.3% | 107,2 k € | +2.0% | 105,1 k € | +10.8% | 94,9 k € | -2.7% | 97,5 k € | +0.7% | 96,8 k € | -8.2% | 105,5 k € | +126.1% | 46,7 k € | +0.2% | 46,6 k € | +7.4% | 43,4 k € | |
| Total assets | 1,4 M € | -13.2% | 1,6 M € | +33.3% | 1,2 M € | +27.5% | 921,7 k € | -5.0% | 970,6 k € | +83.6% | 528,8 k € | +15.7% | 457,1 k € | +1.2% | 451,8 k € | -3.8% | 469,9 k € | -44.5% | 847,1 k € | +13.0% | 749,4 k € | -7.1% | 806,5 k € | -11.0% | 906,6 k € | -34.1% | 1,4 M € | +24.9% | 1,1 M € | +35.5% | 812,8 k € | +84.4% | 440,7 k € | +45.1% | 303,7 k € | +3.8% | 292,7 k € | |
| Cash | 266,5 k € | -59.1% | 651,1 k € | +18.7% | 548,7 k € | +536.5% | 86,2 k € | -1.4% | 87,5 k € | +5.5% | 82,9 k € | +295.1% | 21,0 k € | -47.5% | 40,0 k € | +15.9% | 34,5 k € | -58.9% | 83,8 k € | +52.0% | 55,2 k € | -17.4% | 66,8 k € | -29.7% | 94,9 k € | -53.2% | 202,9 k € | +193.4% | 69,2 k € | +175.0% | 25,2 k € | -57.4% | 59,0 k € | +37.8% | 42,8 k € | -6.7% | 45,9 k € | |
| Debts | 421,6 k € | -44.9% | 765,8 k € | +6.3% | 720,6 k € | +9.8% | 656,3 k € | -13.0% | 754,4 k € | +110.6% | 358,1 k € | -0.7% | 360,6 k € | +2.6% | 351,5 k € | -6.7% | 376,8 k € | -49.5% | 746,8 k € | +16.3% | 642,0 k € | -8.5% | 701,4 k € | -13.6% | 811,7 k € | -34.5% | 1,2 M € | +23.3% | 1,0 M € | +42.1% | 706,9 k € | +79.4% | 394,1 k € | +53.2% | 257,2 k € | +3.2% | 249,3 k € | |
| Staff | 5,8 | 5,8 | 5,3 | 4,8 | 3 | 4,3 | 3,4 | 2,5 | 3,1 | 3,5 | 3,1 | 2,4 | 2,7 | 2,6 | 3,8 | 1,5 | 1,1 | 1,1 | 0,9 | |||||||||||||||||||
Public limited company profitable and well capitalised. Cash position declining (-59.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ECOMAR is a Public limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Ath. It employs on average 5,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette